Lexington-based Imprivata is teaming up with Microsoft to launch healthcare’s first end-to-end Identity and Access Management (IAM) Cloud Platform. The Platform, anchored by Imprivata’s leading solution portfolio and commitment to building trusted digital identities, and the world-class scale and security of Microsoft’s cloud identity platform, Azure Active Directory, will address the unique challenges that healthcare customers face along the digital transformation journey.Phase 1 Collaboration:
Read More
Electronic Prescriptions for Controlled Substances
Can Optimized EHR Data Help Healthcare Combat the Opioid Epidemic?
DrFirst’s Nick Barger explains how the EHR data at the right time can prevent opioids from getting into the wrong hands.While the debate on how to combat the infiltration and abuse of illegal narcotics in the U.S. languished for decades, something more sinister and formidable was growing. This new threat was not lurking in the shadows; instead, it was right under the noses and prescription pads of physicians— opioids.The abuse of prescription opioids has now become a national public health
Read More
Allscripts Taps MedAware to Eliminate Prescription-based Medication Errors
MedAware has been selected by Allscripts patient safety and save lives. This is significant as new interoperability challenges arise created by an all-digital healthcare system. In the US alone, 1.5 million prescription errors per year result in injury or death. Nearly every organization has an EHR and physicians are being bombarded by huge stores of patient data. Allscripts has selected MedAware as its partner to put this data to work – to achieve meaningful interoperability and improve care
Read More
Quick Guide to Electronic Prescriptions for Controlled Substances
Many healthcare providers have delayed implementing electronic prescriptions for controlled substances (EPCS). Some may be waiting for the regulatory dust to settle, as the US Drug Enforcement Agency (DEA) ruling is titled “Interim.” Others may be deterred by the length and complexity of the document.
Despite the temporary title of the DEA’s ruling, EPCS is here to stay. With each passing month, the reasons for implementing EPCS become more compelling. We are reaching a point at which the
Read More
